Correct orientation of the amino and carboxyl groups and of the bicyclic ring of the compound 2-aminonorbornane-2-carboxylic acid is essential for its induction of a tolbutamide-potentiated hypoglycemia in the rat, an effect which we have already shownto arise from stimulation of insulin release.
A partially purified preparation of the non-metabolizable amino acid 2-aminonorbornane-2-carboxylic acid (BCH) ~ produces a tolbutamide-potentiated hypoglycemia in the rat which has been shown to be associated with increases in the immuno!ogically-reactive insulin of the plasma 3. Using a preparation of BCH enriched in one of the geometric isomers which we call (±)b 4, Fajans et a~. 5 showed that the insulin-releasing action of this compound in the dog resembles that of leucine and differs from that of arginine and lysine in four significant aspects.
BCH proved also to be a valuable model substrate for + transport, reacting with principal Na -independent systems in several animal 4,6 cells and tissues , and with a system for branched-chain amino acids in E. coli 4. We have now isolated the four isomers of BCH (Table I) and are reporting here the stereospecificity of their hypoglycemic action in the rat. The ordinate records the change in blood glucose levels by reference to saline-injected controls. The vertical bars represent duplicate experimental animals.
The effect of leucine is shown for reference. The assignments are summarized from reference 8.
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mers, as shown in Table I . Fig. 2 demonstrates that of the optical isomers present in (±)b, only the levorotatory form has measurable hypoglycemic activity. Therefore the dose of biologically active BCH used in the studies of In all other tissues studied in isolation, including segments of hamster intestine, the Ehrlich ascites tumor cell, the pigeon erythrocyte and E. 00~ K-12, we find that the (-)b isomer is transported more rapidly than its enantiomorph, and where tested, with greater apparent affinity. The distributions of the enantiomorphs in the intact rat proved, however, rather similar 12 .
Reactivity of neutral amino acids with a recognition site for stimulating the secretion of insulin is apparently conditioned by the following structural features: (i) The sidechain should have considerable apolar bulk, which can be provided by branching or ring formation; (2) this bulk should be distributed to correspond to an amino acid in its ~ configuration; and (3) a branch on the alpha carbon with the consequent absence of an alpha hydrogen is not detrimental if other steric considerations are met. Beyond these features, we may see that certain dispositions of the mass of the bicycloheptyl ring are unfavorable, and one disposition is favorable. These dispositions can be to some degree mimicked by the isomeric leucines.
We have pointed out earlier how all of the carbon atoms of leucine or isoleucine might be identified each with a carbon atom of BCH 4. In the case
Of L-isoleucine the present results do not disturb whatever validity that placement has in describing a possible orientation for this amino acid at the receptor site.
If we picture its carboxyl group at position C in the sketch of Table I, and its We cannot yet say what latitude is acceptable in the placement of a single sidechain carbon atom at the receptor site, because each of these has not yet been varied independently in a known way. All we say is that the bulk represented by the bicyelic ring structure cannot be received effectively if it is shifted a few ~ngstroms toward the observer, taking the carboxyl and amino groups as points of reference, nor can it be receive= effectively if the cyclopentane ring 1,6,5,4,7 is turned upside down.
The structural requirements for the stimulation of insulin release are remarkably similar to those for transport of the above test amino acids by E. ~oZi I'4'12.
In neither case, however, do we propose that the effect arises from a simple, static occupation of the recognition site; that site presumably must first respond with a significant structural change. Description of that change calls for identification of competitive inhibitors that cannot themselves provoke the response.
Further complementary description of the biological recognition sites and the factors necessary to their responses should be accessible through the test of additional model substrates
